Covid-19 Update

Due to the COVID-19 (coronavirus) outbreak, our office will be closed through Thursday, April 30.

During this time, existing patients can reach us at [email protected].

We invite new patients to use our Online Physician Consult Form or call 212-826-2400.

Robotic Hair Transplants & Hair Restoration
Flagship: 110 East 55th Street, New York, NY
Add'l Loc: 229 7th Street, Garden City, NY
Call Us: 212-826-2400
Bernstein Medical - Center for Hair Restoration
Bernstein Medical In The News

Drs. Schweiger and Bernstein Publish First Case Study Of Latisse For Eyebrow Restoration

Journal of Drugs in DermatologyThe January 2012 issue of the Journal of Drugs in Dermatology contains an article, written by Drs. Schweiger and Bernstein, which is the first case study of eyebrow growth from the topical use of bimatoprost.

Latisse (bimatoprost) is a topical medication that is FDA-approved for eyelash growth. Some physicians have used the medication for “off-label” use, such as use with eyelashes and scalp hair. However, until recently, there had not been any published medical literature describing the off-label use.

Posted by Updated
Bernstein Medical In The News

Hair Cloning “Just A Question Of Time” Dr. Bernstein Tells New York Times

NYT - New Stratagems in the Quest for HairDr. Bernstein is featured in a New York Times article — “New Stratagems in the Quest for Hair” — about the latest advances in hair restoration. The article mentions Dr. Bernstein’s pioneering research on hair cloning, including his studies on hair multiplication using the breakthrough biotechnology of ACell’s MatriStem® extracellular matrix.

Posted by Updated
Hair Restoration Research

Latisse Drug as Hair Loss Treatment? Trials Under Way on New Formulation of Bimatoprost

Latisse, the brand name for the drug bimatoprost, is commonly used to promote eyelash growth in women who want their eyelashes to be longer, thicker, and darker, typically for cosmetic reasons.

In a publication on ClinicalTrials.gov, Allergan, the pharmaceutical company that produces Latisse, has announced a new study on the safety and efficacy of a new formulation of bimatoprost for use as a topical hair loss treatment for general baldness.

Posted by Updated



Browse Hair Restoration Answers by topic: